METABOLIC EFFECTS OF A CHANGE IN ANTIHYPERTENSIVE TREATMENT

被引:9
作者
LITHELL, H [1 ]
ABERG, H [1 ]
SELINUS, I [1 ]
机构
[1] UNIV UPPSALA, DEPT FAMILY MED, S-75012 UPPSALA, SWEDEN
关键词
D O I
10.1016/0002-9343(86)90170-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:114 / 119
页数:6
相关论文
共 45 条
[1]  
ABERG H, 1980, ACTA MED SCAND, V208, P467
[2]  
AMERY A, 1978, LANCET, V1, P681
[3]   IMPROVEMENT OF GLUCOSE-TOLERANCE AND LOWERING OF GLYCOHEMOGLOBIN AND SERUM-LIPID CONCENTRATIONS AFTER DISCONTINUATION OF ANTIHYPERTENSIVE DRUG-THERAPY [J].
AMES, RP ;
HILL, P .
CIRCULATION, 1982, 65 (05) :899-904
[4]   EFFECTS OF TREATMENT ON MORBIDITY IN HYPERTENSION - RESULTS IN PATIENTS WITH DIASTOLIC BLOOD PRESSURES AVERAGING 115 THROUGH 129 MM HG [J].
不详 .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1967, 202 (11) :1028-&
[5]  
[Anonymous], 1981, LANCET, V2, P539
[6]  
[Anonymous], 1980, LANCET, V1, P1261
[7]   METABOLIC EFFECTS OF PRAZOSIN [J].
BARBIERI, C ;
CALDARA, R ;
FERRARI, C ;
DALBO, GA ;
PARACCHI, A ;
ROMUSSI, M ;
CURTARELLI, G .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :313-316
[8]   METABOLIC EFFECTS OF CHRONIC PRAZOSIN TREATMENT [J].
BARBIERI, C ;
FERRARI, C ;
BORZIO, M ;
PIEPOLI, V ;
CALDARA, R .
HORMONE AND METABOLIC RESEARCH, 1980, 12 (07) :331-334
[9]  
BERGLUND G, 1978, LANCET, V1, P1
[10]   HDL CHOLESTEROL AND OTHER LIPIDS IN CORONARY HEART-DISEASE - COOPERATIVE LIPOPROTEIN PHENOTYPING STUDY [J].
CASTELLI, WP ;
DOYLE, JT ;
GORDON, T ;
HAMES, CG ;
HJORTLAND, MC ;
HULLEY, SB ;
KAGAN, A ;
ZUKEL, WJ .
CIRCULATION, 1977, 55 (05) :767-772